TANFIELD VIEW MEDICAL GROUP
SCOTT STREET, TANFIELD, STANLEY
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 21 | 29 | 72.4% | |
| HF 4 | 2011 | 18 | 22 | 81.8% | |
| HF 4 | 2012 | 20 | 22 | 90.9% | |
| HF 4 | 2013 | 28 | 31 | 90.3% | |
| HF004 | 2014 | 16 | 16 | 100.0% | |
| HF004 | 2015 | 27 | 27 | 100.0% | |
| HF004 | 2016 | 34 | 35 | 97.1% | |
| HF004 | 2017 | 42 | 43 | 97.7% | |
| HF004 | 2018 | 51 | 51 | 100.0% | |
| HF004 | 2019 | 65 | 65 | 100.0% | |
| HF004 | 2020 | 63 | 66 | 95.5% | |
| HF006 | 2021 | 76 | 84 | 90.5% | |
| HF006 | 2022 | 122 | 123 | 99.2% | |
| HF006 | 2023 | 129 | 137 | 94.2% |
